IDH2 and central nervous system cancer: In addition to the above-mentioned H3-altered gliomas, extensive heterogeneity in IDH- and histone H3-wild-type pediatric high-grade gliomas (HGG) has been observed, with multiple subgroups displaying differential enrichment of affected oncogenes and clinical features [14, 60].